Mutant p53-induced up-regulation of mitogen-activated protein kinase kinase 3 contributes to gain of function

Aymone Gurtner, Giuseppe Starace, Giuseppe Norelli, Giulia Piaggio, Ada Sacchi, Gianluca Bossi

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Mitogen-activated protein kinase kinase 3 (MAP2K3) is a member of the dual specificity kinase group. Growing evidence links MAP2K3 to invasion and tumor progression. Here, we identify MAP2K3 as a transcriptional target of endogenous gain-of-function p53 mutants R273H, R175H, and R280K. We show thatMAP2K3modulation occurred at the mRNA and protein levels and that endogenous mutant p53 proteins are capable of binding to and activate the MAP2K3 promoter. In addition, we found that the studied p53 mutants regulate MAP2K3 gene expression through the involvement of the transcriptional cofactors NF-Y and NF-κB. Finally, functional studies showed that endogenous MAP2K3 knockdown inhibits proliferation and survival of human tumor cells, whereas the ectopic expression of MAP2K3 can rescue the proliferative defect induced by mutant p53 knockdown. Taken together, our findings define a novel player through which mutant p53 exerts its gain-of-function activity in cancer cells.

Original languageEnglish
Pages (from-to)14160-14169
Number of pages10
JournalJournal of Biological Chemistry
Volume285
Issue number19
DOIs
Publication statusPublished - May 7 2010

Fingerprint

MAP Kinase Kinase 3
Tumors
Up-Regulation
Cells
Gene expression
Neoplasms
Proteins
Phosphotransferases
Mutant Proteins
Protein Binding
Messenger RNA
Defects
Gene Expression
Survival

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Mutant p53-induced up-regulation of mitogen-activated protein kinase kinase 3 contributes to gain of function. / Gurtner, Aymone; Starace, Giuseppe; Norelli, Giuseppe; Piaggio, Giulia; Sacchi, Ada; Bossi, Gianluca.

In: Journal of Biological Chemistry, Vol. 285, No. 19, 07.05.2010, p. 14160-14169.

Research output: Contribution to journalArticle

Gurtner, Aymone ; Starace, Giuseppe ; Norelli, Giuseppe ; Piaggio, Giulia ; Sacchi, Ada ; Bossi, Gianluca. / Mutant p53-induced up-regulation of mitogen-activated protein kinase kinase 3 contributes to gain of function. In: Journal of Biological Chemistry. 2010 ; Vol. 285, No. 19. pp. 14160-14169.
@article{7c01179cdcfb4f94be03c7c65b7fdc54,
title = "Mutant p53-induced up-regulation of mitogen-activated protein kinase kinase 3 contributes to gain of function",
abstract = "Mitogen-activated protein kinase kinase 3 (MAP2K3) is a member of the dual specificity kinase group. Growing evidence links MAP2K3 to invasion and tumor progression. Here, we identify MAP2K3 as a transcriptional target of endogenous gain-of-function p53 mutants R273H, R175H, and R280K. We show thatMAP2K3modulation occurred at the mRNA and protein levels and that endogenous mutant p53 proteins are capable of binding to and activate the MAP2K3 promoter. In addition, we found that the studied p53 mutants regulate MAP2K3 gene expression through the involvement of the transcriptional cofactors NF-Y and NF-κB. Finally, functional studies showed that endogenous MAP2K3 knockdown inhibits proliferation and survival of human tumor cells, whereas the ectopic expression of MAP2K3 can rescue the proliferative defect induced by mutant p53 knockdown. Taken together, our findings define a novel player through which mutant p53 exerts its gain-of-function activity in cancer cells.",
author = "Aymone Gurtner and Giuseppe Starace and Giuseppe Norelli and Giulia Piaggio and Ada Sacchi and Gianluca Bossi",
year = "2010",
month = "5",
day = "7",
doi = "10.1074/jbc.M109.094813",
language = "English",
volume = "285",
pages = "14160--14169",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "19",

}

TY - JOUR

T1 - Mutant p53-induced up-regulation of mitogen-activated protein kinase kinase 3 contributes to gain of function

AU - Gurtner, Aymone

AU - Starace, Giuseppe

AU - Norelli, Giuseppe

AU - Piaggio, Giulia

AU - Sacchi, Ada

AU - Bossi, Gianluca

PY - 2010/5/7

Y1 - 2010/5/7

N2 - Mitogen-activated protein kinase kinase 3 (MAP2K3) is a member of the dual specificity kinase group. Growing evidence links MAP2K3 to invasion and tumor progression. Here, we identify MAP2K3 as a transcriptional target of endogenous gain-of-function p53 mutants R273H, R175H, and R280K. We show thatMAP2K3modulation occurred at the mRNA and protein levels and that endogenous mutant p53 proteins are capable of binding to and activate the MAP2K3 promoter. In addition, we found that the studied p53 mutants regulate MAP2K3 gene expression through the involvement of the transcriptional cofactors NF-Y and NF-κB. Finally, functional studies showed that endogenous MAP2K3 knockdown inhibits proliferation and survival of human tumor cells, whereas the ectopic expression of MAP2K3 can rescue the proliferative defect induced by mutant p53 knockdown. Taken together, our findings define a novel player through which mutant p53 exerts its gain-of-function activity in cancer cells.

AB - Mitogen-activated protein kinase kinase 3 (MAP2K3) is a member of the dual specificity kinase group. Growing evidence links MAP2K3 to invasion and tumor progression. Here, we identify MAP2K3 as a transcriptional target of endogenous gain-of-function p53 mutants R273H, R175H, and R280K. We show thatMAP2K3modulation occurred at the mRNA and protein levels and that endogenous mutant p53 proteins are capable of binding to and activate the MAP2K3 promoter. In addition, we found that the studied p53 mutants regulate MAP2K3 gene expression through the involvement of the transcriptional cofactors NF-Y and NF-κB. Finally, functional studies showed that endogenous MAP2K3 knockdown inhibits proliferation and survival of human tumor cells, whereas the ectopic expression of MAP2K3 can rescue the proliferative defect induced by mutant p53 knockdown. Taken together, our findings define a novel player through which mutant p53 exerts its gain-of-function activity in cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=77951982002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951982002&partnerID=8YFLogxK

U2 - 10.1074/jbc.M109.094813

DO - 10.1074/jbc.M109.094813

M3 - Article

C2 - 20223820

AN - SCOPUS:77951982002

VL - 285

SP - 14160

EP - 14169

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 19

ER -